Results 11 to 20 of about 88,182,083 (298)

Medication Treatment of Opioid Use Disorder [PDF]

Biological Psychiatry, 2020
Opioid use disorder (OUD) is a chronic, relapsing condition, often associated with legal, interpersonal, and employment problems. Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and naltrexone (an opioid antagonist).
James Bell, John Strang
core   +7 more sources

Medication for Adolescents and Young Adults With Opioid Use Disorder [PDF]

Journal of Adolescent Health, 2021
Opioid-related morbidity and mortality have risen in many settings globally. It is critical that practitioners who work with adolescents and young adults (AYAs) provide timely, evidence-based treatment for opioid use disorder (OUD). Such treatment should include medications for opioid use disorder (MOUD), including buprenorphine, naltrexone, and ...
Kreida, Ellen C., Galagali, Preeti M., Akgül, Sinem, Chadi, Nicholas, Aalsma, Matthew C., Hadland, Scott E., Bruner, Ann, Alinsky, Rachel H., Robinson, Camille A., Wilson, J. Deanna   +9 more
openaire   +3 more sources

Medications Development for Treatment of Opioid Use Disorder [PDF]

Cold Spring Harbor Perspectives in Medicine, 2020
This review describes methods for preclinical evaluation of candidate medications to treat opioid use disorder (OUD). The review is founded on the propositions that (1) drug self-administration procedures provide the most direct method for assessment of medication effectiveness, (2) procedures that assess choice between opioid and nondrug reinforcers ...
E. Andrew Townsend, S. Stevens Negus, Matthew L. Banks   +2 more
openaire   +2 more sources

Diagnosing and managing patients with chronic pain who develop prescription opioid use disorder: A scoping review of general practitioners’ experience [PDF]

, 2022
Prescription opioid use disorder is an important sequela of long-term prescribed opioids for chronic ...
Harris-Roxas, B ; https://orcid.org/, Wilson, Hester ; https://orcid.org/, Harris, Mark ; https://orcid.org/, Lintzeris, N   +3 more
core   +1 more source

A Systematic Review Examining Patient and Provider Attitudes Toward Use of Medication for Opioid Use Disorder [paper] [PDF]

, 2023
Introduction: Despite drastically rising rates of opioid overdose related deaths, rigid opinions of both patients and providers against the use of medication for opioid use disorder persist in the face of well-established evidence indicating that ...
Trejo, Anyssa
core   +1 more source

Induction of Medication for Opioid Use Disorder in Primary Care. [PDF]

J Am Board Fam Med
Overdoses and deaths from synthetic opioids grew sharply in the past decade. Most people with opioid use disorder (OUD) do not receive recommended evidence-based treatment: nationally, 72% to 87% of people who need OUD treatment do not receive medication for opioid use disorder (MOUD). Little is known about practice teams' experiences with home, office,
Hall TL, Fernald DH, Jiang V, Curcija K, LeMaster JW, Westfall JM, Nease DE, Zittleman L.   +7 more
europepmc   +4 more sources

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and Alcohol Dependence Reports, 2022
Introduction: Psychosocial support is recommended in conjunction with medication for opioid use disorder (MOUD), although optimal “dose,” modality, and timing of participation is not established.
Kathryn Hefner, Tse-Hwei Choo, Dikla Shmueli-Blumberg, Martina Pavlicova, Jacquie King, Marc Fishman, Matisyahu Shulman, Aimee Campbell, Miranda Greiner, Jennifer Scodes, Sarah Meyers-Ohki, Patricia Novo, Edward Nunes, John Rotrosen   +13 more
doaj   +1 more source

Medication-Assisted Treatment for Opioid-Use Disorder [PDF]

Mayo Clinic Proceedings, 2019
The United States is in the midst of a national opioid epidemic. Physicians are encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 Food and Drug Administration-approved medications to treat OUD (methadone, buprenorphine, and naltrexone) and there is ample evidence of their efficacy, they are not used as often as they
Tyler S. Oesterle, Nuria J. Thusius, Teresa A. Rummans, Mark S. Gold   +3 more
openaire   +2 more sources

Advancing emergency department–initiated buprenorphine

Journal of the American College of Emergency Physicians Open, 2021
Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid‐related overdoses during the COVID‐19 public health emergency.
Kristen Huntley, Emily Einstein, Terri Postma, Anita Thomas, Shari Ling, Wilson Compton   +5 more
doaj   +1 more source

Medications for management of opioid use disorder

American Journal of Health-System Pharmacy, 2019
Abstract Purpose The use of buprenorphine, methadone, and long-acting naltrexone for treatment of opioid use disorder (OUD) is discussed, including a review of current literature detailing treatment approaches and action steps to optimize treatment in acute care and office-based settings.
Jennifer L, Koehl, David E, Zimmerman, Patrick J, Bridgeman   +2 more
openaire   +2 more sources